Repatha

(evolocumab)

1 ML evolocumab 140 MG/ML Auto-Injector [Repatha]1 ML evolocumab 140 MG/ML Prefilled Syringe [Repatha]

View 1 more

NO BOXED WARNING

Dosage & administration

In adults with established CVD or with primary hyperlipidemia:

* The recommended dosage of REPATHA is either 140 mg every 2 weeks OR 420 mg once monthly administered subcutaneously.
* If switching dosage regimens, administer the first dose of the new regimen on the next scheduled date of the prior regimen.

In pediatric patients aged 10 years and older with HeFH:

* The recommended dosage of REPATHA is either 140 mg every 2 weeks OR 420 mg once monthly administered subcutaneously.
* If switching dosage regimens, administer the first dose of the new regimen on the next scheduled date of the prior regimen.

In adults and pediatric patients aged 10 years and older with HoFH:

* The initial recommended dosage of REPATHA is 420 mg once monthly administered subcutaneously.
* The dosage can be increased to 420 mg every 2 weeks if a clinically meaningful response is not achieved in 12 weeks.
* Patients on lipid apheresis may initiate treatment with 420 mg every 2 weeks to correspond with their apheresis schedule. Administer REPATHA after the apheresis session is complete.

* Assess LDL-C when clinically appropriate. The LDL-lowering effect of REPATHA may be measured as early as 4 weeks after initiation.
* Advise latex-sensitive patients that the needle cover of the glass single-dose prefilled syringe and the single-dose prefilled autoinjector contain dry natural rubber, a derivative of latex.
* Administer REPATHA subcutaneously into areas of the abdomen, thigh, or upper arm. Rotate injection sites for each administration.
* See Full Prescribing Information for important administration instructions.

drug label

Repatha prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Repatha prior authorization resources

Most recent Repatha prior authorization forms

View By Payer

Verified: Apr 03, 2024Kaiser Permanente - Mid Atlantic States HMO PCSK9 Inhibitor Agents Prior Authorization Form Maryland/Virginia/Washington DC

Verified: Apr 02, 2024Kaiser Permanente - Virginia Medicaid-FAMIS PCKS9 & ACL Inhibitors Prior Authorization Form Virginia

Verified: Apr 02, 2024Kaiser Permanente - Maryland Health Choice PCSK9 Agents Prior Authorization Form Maryland

Verified: Apr 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington

Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form

Most recent state uniform prior authorization forms

Verified: Mar 28, 2024Arizona - Uniform Prior Authorization Form

Verified: Mar 28, 2024Colorado - Uniform Prior Authorization Form

Verified: Mar 28, 2024Hawaii - Uniform Prior Authorization Form

Verified: Mar 28, 2024Illinois - Uniform Prior Authorization Form

Verified: Mar 28, 2024Indiana - Uniform Prior Authorization Form

Verified: Mar 28, 2024Louisiana - Uniform Prior Authorization Form

Verified: Mar 28, 2024Minnesota - Uniform Prior Authorization Form

Verified: Mar 28, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Mar 28, 2024New Mexico - Uniform Prior Authorization Form

Verified: Mar 28, 2024Oregon - Uniform Prior Authorization Form

Verified: Mar 28, 2024Texas - Uniform Prior Authorization Form

Complete Letter of Medical Necessity

Coverage Authorization Appeals

Coverage Authorization Request (Through CoverMyMeds)

PA Checklist: Atherosclerotic Cardiovascular Disease (ASCVD)

PA Checklist: Familial Hypercholesterolemia (FH)

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Repatha financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

PubMed™ | Repatha

Repatha PubMed™ News

patient education

Repatha patient education

Getting started on Repatha

Intructions For Use: SureClick Autoinjector

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Instructions For Use: Prefilled Syringe

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Instructions For Use: Pushtronex System

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Repatha

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Side Effects

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Stories

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Brochure - Spanish

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

LDL Tracker

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Doctor Discussion Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Repatha FAQs

How is the dosage of Repatha?Repatha is available in 3 dosages, including 120 mg/ml Cartridge 3.5 ml, 140 mg/ml Auto-Injector 1 ml and 140 mg/ml Prefilled Syringe 1 ml

What does Repatha treat?Repatha treats Hypercholesterolemia and Atherosclerosis

What is Repatha made of?Repatha contains evolocumab which is a PCSK9 Inhibitor

How Is Repatha Administered?Repatha is administered as a Injectable

What Are The Repatha Mechanism Of Action?Repatha mechanism of action is PCSK9 Inhibitors

FAQ Data Source

Repatha

Dosage & administration

drug label

Repatha prescribing information

prior authorization

Repatha prior authorization resources

Most recent Repatha prior authorization forms

Most recent state uniform prior authorization forms

Reimbursement help (FRM)

financial assistance

Repatha financial assistance options

Co-pay savings program

PubMed™ | Repatha

Repatha PubMed™ News

patient education

Repatha patient education

Getting started on Repatha

Patient toolkit

people also ask

Repatha FAQs